Brief: Isofol Medical AB- First Patient In Australia Has Initiated Treatment In Global Phase 3 Agent Study
Jan 24 (Reuters) - Isofol Medical AB (publ) ISOFOL.ST :
* ISOFOL MEDICAL AB (PUBL) - FIRST PATIENT IN AUSTRALIA HAS
INITIATED TREATMENT IN GLOBAL PHASE 3 AGENT STUDY
Source text for Eikon: ID:nPn28g4NMa
Further company coverage: ISOFOL.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Isofol Medical AB (publ)
See all newsSweden's Isofol Medical reports no Q2 revenue, net loss widens
Brief: Isofol Medical Q2 Net Income SEK -15.729 Million
Brief: Isofol Medical Adds Clinical Trial Sites To Phase Ib/Ii Arfolitixorin Study In Colorectal Cancer
Sweden's Isofol Medical Q1 net loss widens, raises funds
Brief: Isofol Medical Q1 Net Income SEK -15.062 Million